Proteomics

Dataset Information

0

SOX11-SMARCA4 Complex Drives Oncogenic Gene Regulation in Mantle Cell Lymphoma


ABSTRACT: SOX11 pioneer transcription factor is aberrantly expressed, it has an oncogenic role and its overexpression associates with worse prognosis in patients with mantle cell lymphomas (MCL). Using a proximity labeling (BioID2)/Mass Spectrometry-based proteomic strategyies, we identified SMARCA4, the central catalytic subunit of the SWI/SNF chromatin-remodeling complex, as one of the most significant SOX11-specific interacting proteins. SMARCA4 expression is directly regulated by SOX11, and its upregulation is associated with worse overall survival in patients with MCL, independently of other high-risk factors. Integration of global DNA-binding and transcriptomic profiles revealed that SOX11 and SMARCA4 share 60% specific peaks, predominantly in promoter regions. Disruption of SOX11:SMARCA4 interaction via SOX11 knockout or SMARCA4 PROTAC-degradation significantly reduced co-occupancy and co-targeted gene expression, including key BCR signaling pathway components. Our results suggest that SOX11:SMARCA4 complex binds to common regulatory sequences enabling the accession to chromatin and transcriptomic regulation of key oncogenic pathways for the development of MCL pathogenesis.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell

DISEASE(S): Mantle Cell Lymphoma

SUBMITTER: Paula Carrillo Rodríguez  

LAB HEAD: Virginia Amador

PROVIDER: PXD051143 | Pride | 2025-08-04

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
210819_VirginiaAmador_2021-025.pdStudy Other
4031_FC_V_Ctrl_01_EE.msf Msf
4031_FC_V_Ctrl_01_EE.raw Raw
4031_FC_V_Ctrl_02_EE.msf Msf
4031_FC_V_Ctrl_02_EE.raw Raw
Items per page:
1 - 5 of 19
altmetric image

Publications


Mantle cell lymphoma (MCL) is considered one of the most aggressive B-cell lymphoid neoplasms. The transcription factor SOX11 is aberrantly expressed in conventional aggressive MCL, while it is not or weakly expressed in the leukemic non-nodal MCL subtype with a predominantly indolent clinical evolution. SOX11 is a key driver of MCL through the regulation of several oncogenic mechanisms, suggesting that it may be interacting with different protein complexes to exert its multiple actions. Using p  ...[more]

Similar Datasets

2021-09-22 | PXD023231 | Pride
2023-03-11 | PXD033100 | Pride
2016-06-02 | E-GEOD-74716 | biostudies-arrayexpress
2025-07-16 | PXD043168 | Pride
2012-12-19 | E-GEOD-42917 | biostudies-arrayexpress
2012-12-19 | E-GEOD-42935 | biostudies-arrayexpress
2018-10-26 | PXD005575 | Pride
2018-10-19 | PXD008982 | Pride
2020-11-30 | PXD019920 | Pride
2022-07-11 | PXD025979 | Pride